
Endocrinology/Hormones
Endocrinology/hormone inhibitors are compounds that block the action of hormones or interfere with hormone signaling pathways. These inhibitors are essential for studying the regulation of endocrine systems and for developing treatments for hormone-related diseases, such as diabetes, thyroid disorders, and hormone-dependent cancers. By modulating hormone activity, these inhibitors can help elucidate the complex interactions within the endocrine system. At CymitQuimica, we offer a wide range of high-quality endocrinology/hormone inhibitors to support your research in endocrinology, pharmacology, and medical sciences.
Subcategories of "Endocrinology/Hormones"
- Androgen Receptor(207 products)
- Annexin A(11 products)
- Aromatase(20 products)
- Estrogen/progestogen Receptor(49 products)
- GPR(1 products)
- Glucocorticoid Receptor(153 products)
- LHRH(1 products)
- Opioid Receptor(296 products)
- Prostaglandin Receptor(119 products)
- RAAS(86 products)
- Reductase(52 products)
- Somatostatin(46 products)
- Thyroid hormone receptor(THR)(26 products)
- Vasopressin Receptor(44 products)
Show 6 more subcategories
Found 3178 products of "Endocrinology/Hormones"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
TRβ agonist 1
CAS:<p>TRβ Agonist 1, a selective and mutation-sensitive thyroid hormone receptor β (TRβ) agonist, demonstrates an EC50 value of 21 nM.</p>Formula:C29H25FN2O8Color and Shape:SolidMolecular weight:548.52PD 134922
CAS:<p>PD 134922 is a HIV-1 protease inhibitors. Inactivation of the protease prevents infectious virion formation.</p>Formula:C37H61N5O7SPurity:98%Color and Shape:SolidMolecular weight:719.97rel-SB-612111 hydrochloride
CAS:<p>NOP receptor antagonist</p>Formula:C24H30Cl3NOPurity:98%Color and Shape:SolidMolecular weight:454.86JNJ-1250132
CAS:<p>JNJ-1250132 is a steroidal progesterone receptor modulator that inhibits binding of the receptor to DNA in vitro.</p>Formula:C33H41NO4Color and Shape:SolidMolecular weight:515.68GPR84 antagonist 3
CAS:<p>Potent GPR84 antagonist 3 (compound 42), pIC50 8.28, inhibits GTPγS, with good pharmacokinetics.</p>Formula:C29H27N5OColor and Shape:SolidMolecular weight:461.56Androgen receptor degrader-5
CAS:<p>Androgen receptor degrader-5 (compound 14k) demonstrates superior capabilities, specifically in androgen receptor degradation and antiproliferative activity, showcasing its promising properties.</p>Formula:C29H25F4N5O2Color and Shape:SolidMolecular weight:551.53Sunobinop
CAS:<p>Sunobinop (S 117957) is an opioid receptor-like orphan receptor (ORL1) modulator.</p>Formula:C26H33N3O3Color and Shape:SolidMolecular weight:435.56Norbinaltorphimine dihydrochloride
CAS:<p>Norbinaltorphimine dihydrochloride is a selective and potent κ opioid receptor antagonist that induces itch-associated responses in mice.</p>Formula:C40H45Cl2N3O6Purity:98.17% - 99.88%Color and Shape:SolidMolecular weight:734.71SC13
CAS:<p>SC13, a novel mitragynine analog, exhibits low-efficacy agonism at Mu opioid receptors and provides antinociception while minimizing adverse effects.</p>Formula:C26H30N2O5Color and Shape:SolidMolecular weight:450.53FL442
CAS:<p>FL442 is an Androgen Receptor (AR) modulator. This compound exhibits potent inhibitory effects in AR-dependent prostate cancer cells, showing similar suppression efficiency to the traditional antiandrogen drugs Bicalutamide and Enzalutamide. It also maintains antiandrogen activity against the Enzalutamide-resistant AR mutant F876L. The pharmacokinetic properties of FL442 in mice reveal a longer half-life (8 hours), excellent targeting (prostate tissue), and metabolic stability. Additionally, it is effective at inhibiting LNCaP tumor growth at low plasma concentrations (30 ng/mL).</p>Formula:C15H13F3N2OColor and Shape:SolidMolecular weight:294.27LY2066948
CAS:<p>LY2066948 is a selective oral estrogen receptor modulator (SERM) with high affinity for estrogen receptors ERα and ERβ (Ki of 0.51 and 1.36 nM, respectively) and displays potent anti-estrogenic activity. It effectively blocks the increase in uterine weight induced by ethinylestradiol in immature rats. LY2066948 is utilized in the research of uterine fibroids and myomas.</p>Formula:C30H31NO5SColor and Shape:SolidMolecular weight:517.64CCG258747
CAS:<p>CCG258747 is a novel, selective inhibitor of the GRK2 subfamily.</p>Formula:C28H27FN4O4Color and Shape:SolidMolecular weight:502.54MK-6913
CAS:<p>MK-6913 is a potent and selective agonist of estrogen receptor β.</p>Formula:C25H27N3O2Purity:98%Color and Shape:SolidMolecular weight:401.5Elacestrant S enantiomer dihydrochloride
<p>Elacestrant (RAD1901) dihydrochloride, an oral ERR degrader, has IC50 of 48 nM (ERα) and 870 nM (ERβ). Its S enantiomer has low activity.</p>Formula:C30H40Cl2N2O2Purity:98%Color and Shape:SolidMolecular weight:531.56A 74273
CAS:<p>A 74273, a nonpeptidic and renin inhibitor, may be used to treat cardiovascular diseases due to renin inhibition.</p>Formula:C44H74N4O8Purity:98%Color and Shape:SolidMolecular weight:787.08Estrogen receptor antagonist 6
CAS:<p>Estrogen receptor antagonist 6 is a potent blocker of estrogen signaling, regulating various biological effects. (Compound 166)</p>Formula:C25H31F3N2O3Color and Shape:SolidMolecular weight:464.52(+)-JJ-74-138
CAS:<p>(+)-JJ-74-138 is a novel non-competitive androgen receptor (AR) antagonist capable of inhibiting enzalutamide-resistant castration-resistant prostate cancer (CRPC).</p>Formula:C22H22F8N2OSColor and Shape:SolidMolecular weight:514.48Mu opioid receptor antagonist 4
<p>Compound 31: Potent, selective MOR antagonist; crosses blood-brain barrier; Ki & EC50: 0.38 nM; useful for OUD research.</p>Formula:C25H28N2O4SColor and Shape:SolidMolecular weight:452.57σ1 Receptor/μ Opioid receptor modulator 2
CAS:<p>Compound 4x, also known as σ1 Receptor/μOpioid receptormodulator 2, acts as a μOR agonist and a σ1R antagonist, exhibiting a potent μOR EC50 of 0.6 nM and strong σ1R inhibitory activity (Ki: 363.7 nM). It demonstrates significant analgesic effects in various pain models.</p>Formula:C23H31N3OMolecular weight:365.51RJG-2051
CAS:<p>RJG-2051 is a selective covalent inhibitor of aldo-keto reductase family 1 member C3 (AKR1C3), with an IC50 value of 13 nM. It interferes with the metabolism of substrates such as androgens, estrogens, and prostaglandins through AKR1C3. RJG-2051 holds potential for cancer research.</p>Formula:C26H31N5O4SColor and Shape:SolidMolecular weight:509.62

